[Is quantification of HBsAg levels useful in the follow-up of patients with chronic hepatitis B virus infection?].
Unidad de Hepatología, Hospital Carlos III, CIBERehd, Madrid, España.
Miriam
M
Romero
Unidad de Hepatología, Hospital Carlos III, CIBERehd, Madrid, España.
Antonio
A
Madejón
Unidad de Hepatología, Hospital Carlos III, CIBERehd, Madrid, España. Electronic address: javiersamaniego@telefonica.net.
Javier
J
García-Samaniego
D000998:Antiviral Agents / Q000627:therapeutic use; D015415:Biomarkers; D002353:Carrier State / Q000097:blood / Q000175:diagnosis; D004279:DNA, Viral / Q000097:blood; D018450:Disease Progression; D016903:Drug Monitoring; D005500:Follow-Up Studies; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006515:Hepatitis B virus / Q000235:genetics / Q000302:isolation & purification; D019694:Hepatitis B, Chronic / Q000097:blood* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D008111:Liver Function Tests
D000998:Antiviral Agents; D015415:Biomarkers; D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens